Nature’S Sun Stock Price, News & Analysis

Nature’s Sunshine (Nasdaq: NATR) will hold its third quarter 2025 conference call on Thursday, November 6, 2025 at 5:00 p.m. ET (3:00 p.m. MT) to discuss financial results for the quarter ended September 30, 2025.

CEO Kenneth Romanzi and CFO Shane Jones will host the call. The company will release results in a press release prior to the call. Participants should dial in 5–10 minutes early for registration.

• Toll-free dial-in: 1-800-717-1738
• International dial-in: 1-646-307-1865
• Conference ID: 34830
• Replay available after 8:00 p.m. ET on Nov 6, 2025 through Nov 20, 2025 (toll-free replay: 1-844-512-2921, replay ID 1134830)

Nature’s Sunshine (Nasdaq: NATR) appointed Kenneth Romanzi as Chief Executive Officer and member of the board, effective October 29, 2025. The board made a unanimous decision following a comprehensive search. Romanzi joins with extensive CPG leadership experience, including prior roles as President and CEO of B&G Foods where full-year revenue grew from $1.6 billion to $2.0 billion, plus executive positions at Nabisco, Naked Juice/The Ultimate Juice Company, Hasbro, and Ocean Spray.

Management expects Romanzi to accelerate digital empowerment of distributors, expand omnichannel offerings, and drive long-term shareholder value while building on existing momentum under outgoing CEO Terrence Moorehead.

Nature’s Sunshine (Nasdaq: NATR) relaunched its Power Line on October 7, 2025, adding a new product, Power Balance, to a four-supplement suite targeting metabolic health.

The updated line includes Power Beets (cardiovascular support), Power Greens (nutrient-dense greens), Power Meal (plant-protein meal replacement with 30+ whole foods), and new Power Balance (premeal metabolic optimizer with a superfood fiber matrix to curb cravings, balance blood sugar, and support the microbiome).

The company positions the suite as a natural, convenient approach to address rising global metabolic health concerns and to complement modern diets.

Nature's Sunshine (NASDAQ:NATR) reported strong Q2 2025 financial results with net sales increasing 4% to $114.8 million compared to $110.6 million in the year-ago quarter. The company's GAAP net income rose significantly to $5.3 million ($0.28 per diluted share) from $1.3 million ($0.07 per diluted share).

Key performance metrics include Adjusted EBITDA growth of 8% to $11.3 million, improved gross profit margin of 71.7%, and strong performance in Japan and Central Europe. The company has revised its full-year 2025 guidance upward, now expecting net sales between $460-$475 million and adjusted EBITDA of $41-$45 million.

Nature's Sunshine Products (NASDAQ: NATR), a leading manufacturer of herbal and nutritional supplements, has scheduled its Q2 2025 earnings conference call for Thursday, July 31, 2025, at 5:00 p.m. ET. CEO Terrence Moorehead and CFO Shane Jones will host the call.

The company will release its financial results before the call, followed by a Q&A session. The call will be accessible via toll-free dial-in (1-800-717-1738) and international dial-in (1-646-307-1865) numbers. A replay will be available until August 14, 2025, and the call will be broadcast live on Nature's Sunshine's website.

Nature's Sunshine Products (NASDAQ: NATR) announced the pricing of a secondary public offering where Fosun Pharma USA will sell up to 2,854,607 shares of common stock at $12.00 per share. The offering is expected to close on June 27, 2025.

While NATR won't receive any proceeds from the offering, the company may purchase up to $15.0 million worth of shares from underwriters as part of its existing share repurchase program. D.A. Davidson & Co. is serving as the sole book-running manager for the offering.

Nature's Sunshine Products (NASDAQ: NATR) has announced a secondary public offering of up to 2,854,607 shares of common stock to be sold by Fosun Pharma USA. The company itself is not selling any shares and will not receive proceeds from the offering. As part of the offering, Nature's Sunshine may purchase up to $15.0 million of shares through its existing share repurchase program, funded by cash on-hand and credit facility.

D.A. Davidson & Co. is serving as the sole book-running manager for the offering, which is being made pursuant to an effective shelf registration statement filed with the SEC on June 9, 2025.

Nature's Sunshine Products (NATR) has renewed its scholarship partnership with the University of Utah's David Eccles School of Business, pledging $200,000 over four years to support economically disadvantaged students. The scholarship, part of the Opportunity Scholars program, provides full-ride funding to first-generation college students. Recipients will have access to comprehensive support including mentors, tutors, academic advising, and networking opportunities. The initiative, managed through Nature's Sunshine's Impact Foundation, was established in response to social events of 2020 and will continue through the 2027-2028 academic year. CEO Terrence Moorehead emphasized the company's commitment to helping people reach their potential through education, while Dean Kurt Dirks highlighted the transformative impact of higher education on students, their families, and communities.

Nature's Sunshine Products (NATR) announced that CEO Terrence Moorehead will step down from his position as President, CEO, and Board member once a successor is appointed. The Board has initiated a comprehensive search process with a national executive search firm to find the next CEO. Moorehead, who has served as CEO since 2018, led the company through significant transformations, including strengthening fundamentals, brand revitalization, and digital initiatives. Under his nearly seven-year tenure, the company enhanced its competitiveness and built a foundation for long-term growth. Board Chairman Heidi Wissmiller acknowledged Moorehead's leadership through global uncertainty and the company's positioning with upgraded digital capabilities and an integrated business model. Nature's Sunshine reaffirmed its previously announced full-year 2025 outlook for net sales and adjusted EBITDA.